Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting cobalt-CHromium Stent and platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction Identically DeSigned bare-Metal stent in patients with Acute Myocardial Infarction: MECHANISM-AMI
- Conditions
- Coronary Artery Disease
- Registration Number
- JPRN-UMIN000014440
- Lead Sponsor
- Iwate Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1) Patients who are judged incapable of undergoing clinical follow-up 12 months after PCI (Consider also the location of patients' residences) 2) Lack of specific findings of ACS by angiography (Left to the operator's decision.) 3) Shock 4) The culprit lesion is the left main coronary trunk 5) Lesion with the reference vascular diameter less than 2.0mm or not less than 4.5mm by visual evaluation. 6) AMI due to stent thrombosis at prior stented segment. 7) Chronic renal failure with serum creatinine level not less than 2.0mg/dl on hospital visit 8) Patients on hemodialysis 9) Cancer patients whose vital prognosis is expected to be within 2 years. 10) Surgery that requires discontinuation of the antiplatelet agent is scheduled within 3 months. 11) Female patient plan to became pregnant or during pregnancy. 12) Patients who experienced adverse reaction to aspirin or clopidogrel (this shall not apply for patients in whom safety of ticlopidine is confirmed)
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of stent strut coverage by OCT at 2-week or 3-months
- Secondary Outcome Measures
Name Time Method